59MDWI44-107 governs blood product policies, procedures, and responsibilities for limited transfusion services at Wilford Hall.
View 59MDWI44-107 on armypubs.army.mil
It covers product availability, emergency release and issue of blood, administration of blood components, transfusion reactions, and massive transfusions. It requires compliance with regulatory requirements, standards, and Current Good Manufacturing Practices.
Applies to: This instruction applies to all Military Medical Treatment Facilities (MTFs) and Clinics under the Authority, Direction, and Control of the Director, Wilford Hall Ambulatory Surgical Center, to include the 59th Medical Wing (MDW) medical staff while performing Defense Health Agency duties.
Allogeneic packed red blood cells (pRBC) is the only product available through Transfusion Services. (paragraph 2)
The Transfusion Service maintains a routine inventory of 6 pRBC units: 2 O Negative and 4 O Positive units which will be maintained for emergency release use only. (paragraph 2)
Emergency Release will be available 24/7 for the Family Emergency Center and the Wilford Hall Ambulatory Surgical Center (WHASC) Operating Room/Post-Anesthesia Care Unit surgical cases only. (paragraph 2)
The patient's full name, unique patient identification number [Department of Defense Identification (DOD ID #)] and date of birth (DOB) are required when requesting emergency blood products. (paragraph 4)
When a patient requires immediate transfusion with emergency-released group O pRBC, TWO properly labeled patient sample tubes drawn into PREFERABLY an Ethylene Diaminetetraacetic Acid [K2 Ethylene Diaminetetraacetic Acid (EDTA) PINK TOP] or ALTERNATELY a red top clot tube must be collected BEFORE starting the transfusion to enable the blood bank to determine the patient's ABO and Rh and perform compatibility testing. (paragraph 4)